Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.

Saved in:
Bibliographic Details
Title: Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Authors: Korell, Felix1 (AUTHOR) felix.korell@med.uni-heidelberg.de, Schubert, Maria-Luisa1 (AUTHOR) Tim.Sauer@med.uni-heidelberg.de, Sauer, Tim1 (AUTHOR) Anita.Schmitt@med.uni-heidelberg.de, Schmitt, Anita1 (AUTHOR) Patrick.Derigs@med.uni-heidelberg.de, Derigs, Patrick1 (AUTHOR) carsten.mueller-tidow@med.uni-heidelberg.de, Weber, Tim Frederik2 (AUTHOR) Tim.Weber@med.uni-heidelberg.de, Schnitzler, Paul3 (AUTHOR) paul.schnitzler@med.uni-heidelberg.de, Müller-Tidow, Carsten1 (AUTHOR) Peter.Dreger@med.uni-heidelberg.de, Dreger, Peter1 (AUTHOR) michael.schmitt@med.uni-heidelberg.de, Schmitt, Michael1 (AUTHOR), Pabst, Thomas (AUTHOR)
Source: Cancers. Apr2021, Vol. 13 Issue 7, p1684-1684. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers13071684